To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene NFKBIL2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
91 supporting clones for gene NFKBIL2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CN366457 embryonic stem cells, cell lines H1, H7, andH9 .a 1 to 553 25 to 577   tiling clone,   553/577
(95 %)
6 diff
(99.0 %id)
NM_013432.4   .a 1 to 4519 1 to 4519 exact RefSeq,   4519/4519
(100 %)
4 diff
(100.0 %id)
BF314727 brain, neuroblastoma .a 28 to 725 1 to 708       708/1101
(64 %)
32 diff
(97.1 %id)
BF316742 brain, neuroblastoma .a 28 to 767 1 to 768       735/975
(75 %)
59 diff
(94.0 %id)
BC008782 Brain, neuroblastoma .a 29 to 4487 1 to 4459   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 4459/4459
(100 %)
3 diff
(100.0 %id)
BM193972 leukopheresis .a 30 to 521 1 to 492       492/492
(100 %)
2 diff
(99.6 %id)
BQ960372 leiomyosarcoma, uterus .a 35 to 956 1 to 928       928/929
(99 %)
10 diff
(99.0 %id)
BE383502 brain, neuroblastoma .a 212 to 613 20 to 420       401/421
(95 %)
8 diff
(98.1 %id)
U16258   .a 422 to 1977 254 to 1804       1551/1813
(85 %)
29 diff
(98.5 %id)
DR432873 mixed .a 488 to 1167 1 to 673       673/673
(100 %)
11 diff
(98.4 %id)
TI_1948150890   .a 489 to 1312 120 to 947       828/1061
(78 %)
19 diff
(98.3 %id)
TI_1948151163   .a 489 to 1025 125 to 666       542/1460
(37 %)
17 diff
(98.9 %id)
TI_1948151164   .a 489 to 1369 122 to 1009       888/1055
(84 %)
21 diff
(98.1 %id)
TI_1948151434   .a 489 to 1126 125 to 768       644/1426
(45 %)
31 diff
(97.9 %id)
TI_1948151435   .a 489 to 1284 121 to 927       807/1137
(70 %)
27 diff
(97.7 %id)
TI_1948151716   .a 489 to 1032 124 to 667       544/1391
(39 %)
13 diff
(99.1 %id)
TI_1948151717   .a 489 to 1364 122 to 1002   AAA   881/1048
(84 %)
23 diff
(97.9 %id)
CV026735 mixed .a 493 to 1165 1 to 672       672/673
(99 %)
9 diff
(98.7 %id)
CN366453 embryonic stem cells, cell lines H1, H7, andH9 .a 677 to 1305 1 to 631       629/631
(99 %)
4 diff
(99.4 %id)
CN366458 embryonic stem cells, cell lines H1, H7, andH9 .a 697 to 1344 1 to 649       649/649
(100 %)
5 diff
(99.3 %id)
BU154566 melanotic melanoma, skin .a 728 to 1424 1 to 697       697/943
(73 %)
8 diff
(99.2 %id)
BM463971 melanotic melanoma, skin .a 1070 to 1912 20 to 865       846/1096
(77 %)
24 diff
(97.9 %id)
BE407508 choriocarcinoma, placenta .a 1112 to 1786 1 to 675       675/682
(98 %)
13 diff
(98.1 %id)
BQ230076 embryonal carcinoma, cell line, testis .a 1163 to 1957 1 to 798       798/817
(97 %)
8 diff
(99.1 %id)
BM477754 leiomyosarcoma, uterus .a 1448 to 2124 1 to 683       683/1170
(58 %)
11 diff
(99.1 %id)
CB594872 Blood, promyelocytic leukemia .a 1450 to 2321 1 to 880       880/895
(98 %)
12 diff
(98.7 %id)
BG392570 embryonal carcinoma, cell line, testis .a 1495 to 2167 15 to 694       680/699
(97 %)
44 diff
(93.8 %id)
BM903924 eye, retinoblastoma .a 1495 to 2358 8 to 878       871/970
(89 %)
28 diff
(97.2 %id)
CN366456 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1505 to 2142 1 to 637       637/637
(100 %)
1 diff
(99.9 %id)
BQ379444 uterus_tumor .a 1728 to 2029 339 to 37       303/347
(87 %)
21 diff
(94.0 %id)
BF954610 nervous_normal .a 1854 to 2235 474 to 93       382/483
(79 %)
3 diff
(99.4 %id)
CN366452 embryonic stem cells, cell lines H1, H7, andH9 .a 1936 to 2474 1 to 539       539/539
(100 %)
1 diff
(99.9 %id)
BU170341 eye, retinoblastoma .a 1947 to 2707 6 to 778       773/885
(87 %)
51 diff
(94.3 %id)
BG284527 adenocarcinoma, cell line, Prostate .a 1968 to 2759 1 to 783   tiling clone,   783/1140
(68 %)
25 diff
(97.9 %id)
BI117416 lung, small cell carcinoma .a 2128 to 2866 1 to 740       740/854
(86 %)
23 diff
(97.4 %id)
BQ434690 eye, retinoblastoma .a 2308 to 2868 1 to 562       562/928
(60 %)
19 diff
(98.0 %id)
BG341781 B-cells, primary B-cells from tonsils (cell line) .a 2436 to 3024 206 to 786       690/980
(70 %)
48 diff
(95.2 %id)
CN366454 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2505 to 3215 1 to 712       712/712
(100 %)
1 diff
(99.9 %id)
BE871368 adenocarcinoma, colon .a 2520 to 2882 1 to 363       363/363
(100 %)
0 diff
(100 %id)
BU190662 melanotic melanoma, cell line, skin .a 2523 to 3341 1 to 832       832/890
(93 %)
24 diff
(97.4 %id)
BU161660 melanotic melanoma, skin .a 2629 to 3354 1 to 734       734/898
(81 %)
17 diff
(98.2 %id)
CN366455 embryonic stem cells, cell lines H1, H7, andH9 .a 2698 to 3252 10 to 564       555/564
(98 %)
6 diff
(99.0 %id)
BU190557 melanotic melanoma, cell line, skin .a 2857 to 3694 1 to 850       850/920
(92 %)
27 diff
(97.1 %id)
BU145350 epidermoid carcinoma, cell line, salivary gland .a 2857 to 3577 1 to 721       721/990
(72 %)
18 diff
(98.2 %id)
BQ673546 epidermoid carcinoma, cell line, salivary gland .a 2857 to 3388 1 to 532       532/926
(57 %)
17 diff
(98.2 %id)
BQ669627 epidermoid carcinoma, cell line, salivary gland .a 2857 to 3575 1 to 720       720/965
(74 %)
25 diff
(97.5 %id)
BU173679 melanotic melanoma, cell line, skin .a 2858 to 3577 1 to 723       723/891
(81 %)
16 diff
(98.3 %id)
CX873543 embryonic stem .a 2960 to 3795 1 to 836       836/836
(100 %)
0 diff
(100 %id)
BM918035 blood, natural killer cells, cell line .a 2997 to 3940 1 to 952       952/1043
(91 %)
25 diff
(97.7 %id)
BM799907 eye, retinoblastoma .a 3014 to 3823 21 to 831       815/1100
(74 %)
18 diff
(98.4 %id)
BM043869 carcinoma, cell line, Prostate .a 3033 to 3794 1 to 760       760/760
(100 %)
8 diff
(99.0 %id)
BM048623 carcinoma, cell line, Prostate .a 3033 to 3789 1 to 757       757/758
(99 %)
4 diff
(99.5 %id)
BM046160 carcinoma, cell line, Prostate .a 3033 to 3822 1 to 790       790/821
(96 %)
12 diff
(98.6 %id)
BQ944722 carcinoma, cell line, Prostate .a 3035 to 3747 1 to 714       714/934
(76 %)
11 diff
(98.9 %id)
TI_1948150891   .a 3223 to 4154 1073 to 125       949/1340
(70 %)
49 diff
(96.4 %id)
TI_1948151719   .a 3223 to 4154 1053 to 131       923/1366
(67 %)
22 diff
(98.4 %id)
TI_1948151165   .a 3233 to 4154 1049 to 125       925/1280
(72 %)
28 diff
(97.9 %id)
TI_1948151718   .a 3234 to 4154 1044 to 125       920/1285
(71 %)
31 diff
(97.6 %id)
TI_1948151437   .a 3275 to 4154 1002 to 130       873/1391
(62 %)
18 diff
(98.8 %id)
BF772202 epid_tumor .a 3303 to 3479 5 to 177       173/177
(97 %)
11 diff
(93.8 %id)
TI_1948151436   .a 3333 to 4154 950 to 125       826/1325
(62 %)
17 diff
(98.8 %id)
DR432369 mixed .a 3371 to 4154 781 to 3       779/787
(98 %)
13 diff
(98.4 %id)
TI_1948150892   .a 3400 to 4154 878 to 128       751/1356
(55 %)
12 diff
(99.2 %id)
TI_1948151166   .a 3403 to 4154 879 to 134       746/1328
(56 %)
8 diff
(99.4 %id)
BG390892 embryonal carcinoma, cell line, testis .a 3447 to 4156 1 to 705       705/773
(91 %)
16 diff
(98.0 %id)
DR432502 mixed .a 3495 to 4154 662 to 3       660/662
(99 %)
0 diff
(100 %id)
BI092283 cervix .a 3533 to 4330 1 to 799       797/805
(99 %)
19 diff
(97.7 %id)
BE877350 large cell carcinoma, undifferentiated, lung .a 3601 to 4173 1 to 576       576/577
(99 %)
8 diff
(98.7 %id)
BE877453 large cell carcinoma, undifferentiated, lung .a 3602 to 4313 1 to 724       724/825
(87 %)
39 diff
(95.3 %id)
BG819532 anaplastic oligodendroglioma with 1p/19qloss, brain .a 3654 to 4334 1 to 679       679/679
(100 %)
4 diff
(99.5 %id)
BQ081862 Ascites, stomach .a 3706 to 4222 1 to 518       518/518
(100 %)
6 diff
(98.9 %id)
BU632795 cell lines, Chondrosarcoma .a 3749 to 4213 483 to 19   AAA   465/469
(99 %)
1 diff
(99.8 %id)
BU597311 mixed (pool of 40 RNAs) .a 3892 to 4513 1 to 623       623/900
(69 %)
11 diff
(98.8 %id)
BI861705 breast, mammary adenocarcinoma, cell line .a 3956 to 4503 40 to 589       550/629
(87 %)
8 diff
(98.8 %id)
BM479763 embryonal carcinoma, cell line, testis .a 3956 to 4520 1 to 568   tiling clone, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 568/568
(100 %)
1 diff
(99.9 %id)
TI_57191796   .a 3956 to 4503 168 to 717       550/1125
(48 %)
8 diff
(99.3 %id)
BY798625 eye .a 4063 to 4213 1 to 151       151/152
(99 %)
1 diff
(99.4 %id)
AL041690 testis .a 4150 to 4513 387 to 23   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 365/365
(100 %)
6 diff
(98.4 %id)
BF475381 sciatic nerve .a 4151 to 4515 370 to 5       366/370
(98 %)
0 diff
(100 %id)
H46122 brain .a 4216 to 4592 385 to 1   tiling clone, Submitted on the opposite strand 385/397
(96 %)
28 diff
(93.0 %id)
H40936 brain .a 4236 to 4580 357 to 12   tiling clone, Submitted on the opposite strand 346/376
(92 %)
0 diff
(100 %id)
AB209126 brain .b 1 to 6600 1 to 6601 G129S tiling clone,   6601/6601
(100 %)
19 diff
(99.8 %id)
AK097406 testis .b 4073 to 6574 1 to 2502   available from FLJ,   2502/2502
(100 %)
12 diff
(99.6 %id)
DB022215 testis .b 4074 to 4601 2 to 529   capped   528/528
(100 %)
2 diff
(99.7 %id)
DB151761 thymus .b 4872 to 5410 2 to 540   capped   539/539
(100 %)
5 diff
(99.1 %id)
BM916933 blood, natural killer cells, cell line .c 1 to 1080 13 to 1113 C3T S4Q S5Q D6* tiling clone,   1049/1124
(93 %)
50 diff
(95.6 %id)
BQ377606 uterus .d-u 1 to 362 364 to 7   tiling clone,   358/369
(97 %)
0 diff
(100 %id)
BG284976 adenocarcinoma, cell line, Prostate .d-u 142 to 752 1 to 610   tiling clone,   610/610
(100 %)
1 diff
(99.9 %id)
CR978736 T-Lymphocytes .d-u 230 to 842 1 to 613   tiling clone,   613/622
(98 %)
2 diff
(99.7 %id)
BG819193 anaplastic oligodendroglioma with 1p/19qloss, brain .d-u 234 to 798 1 to 557       557/582
(95 %)
13 diff
(97.8 %id)
DB371847 ovary, tumor tissue Gene NFKBIL2, variant not shown       fully sequenced, This clone was ignored    
DA812479 ovary, tumor tissue Gene NFKBIL2, variant not shown       fully sequenced, capped This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI